ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Corgi All World 2x Daily ETF
24.63
+0.4216
1.74%
盤後:
24.66
0.0287
+0.12%
16:10 EDT
成交量:
134
成交額:
3,301
市值:
36.95萬
市盈率:
- -
高:
24.66
開:
24.66
低:
24.63
收:
24.21
52周最高:
25.58
52周最低:
20.48
股本:
1.50萬
流通股本:
1.50萬
量比:
0.49
換手率:
0.89%
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞
【券商聚焦】中信證券:上半年CXO及生命科學上游板塊整體表現穩健,CRO有望量價齊升
金吾财讯
·
09/11
東北證券:創新藥BD和商業化持續兑現 CXO超預期,傳統板塊築底拐點
智通财经
·
09/10
分拆上市成利好?金斯瑞大反攻,飆升逾12%!華寶基金港股通醫療ETF(159137)標的指數漲近2%,CXO全線提振
新浪基金
·
09/08
昊海生科:關於參加科創板2026年半年度生物製品及CXO行業集體業績説明會的公告
证券日报网
·
09/07
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/WX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"WX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WX\",,,,,undefined,":{"symbol":"WX","market":"US","secType":"STK","nameCN":"Corgi All World 2x Daily ETF","latestPrice":24.6313,"timestamp":1789156800000,"preClose":24.2097,"halted":0,"volume":134,"hourTrading":{"tag":"盘后","latestPrice":24.66,"preClose":24.6313,"latestTime":"16:10 EDT","volume":6,"amount":147.7878,"timestamp":1789157404974,"change":0.0287,"changeRate":0.001165,"amplitude":0},"delay":0,"changeRate":0.017414507408187542,"floatShares":15000,"shares":15000,"eps":0,"marketStatus":"未開盤","change":0.4216,"latestTime":"09-11 16:00:00 EDT","open":24.66,"high":24.66,"low":24.6313,"amount":3301,"amplitude":0.001185,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"exchange":"CBOE","adjPreClose":24.2097,"nav":24.19,"aum":362850,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.66,"preClose":24.6313,"latestTime":"16:10 EDT","volume":6,"amount":147.7878,"timestamp":1789157404974,"change":0.0287,"changeRate":0.001165,"amplitude":0},"volumeRatio":0.48550745746701046},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WX\",,,,,undefined,":{"symbol":"WX","floatShares":15000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.48550745746701046,"shares":15000,"dividePrice":0,"high":24.66,"amplitude":0.001185,"preClose":24.2097,"low":24.6313,"week52Low":20.48,"pbRate":"--","week52High":25.58,"institutionHeld":0,"latestPrice":24.6313,"eps":0,"divideRate":0,"volume":134,"delay":0,"ttmEps":0,"open":24.66,"prevYearClose":24.72,"prevWeekClose":25.2148,"prevMonthClose":24.9073,"prevQuarterClose":23.5672,"fiveDayClose":25.243,"twentyDayClose":25.5654,"sixtyDayClose":23.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666917512","title":"【券商聚焦】中信證券:上半年CXO及生命科學上游板塊整體表現穩健,CRO有望量價齊升","url":"https://stock-news.laohu8.com/highlight/detail?id=2666917512","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666917512?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 09:07","pubTimestamp":1789088866,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研究指,2026年上半年,CXO板块及生命科学上游板块整体业绩表现稳健,行业进入复苏阶段。上半年海外投融资景气度持续,美联储加息预期走弱,早研板块整体的景气度持续走强,AIDD的快速发展也将进一步催化未来相关实验和验证需求的爆发,该机构认为CRO板块有望量价齐升。CDMO板块上半年龙头业绩表现稳健,整体订单增速持续加快,行业景气度回升。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991341","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821","WX","03933","01530","LU0244354667.USD","BK0188","06160","09926","LU0540923850.HKD","BK1100","LU0405327494.USD","LU1997245177.USD","LU2328871848.SGD","LU2778985437.USD","LU1997245094.SGD","09688","LU1794554557.SGD","BK1593","06030","LU2476274308.USD","02228","LU0561508036.HKD","LU0348827113.USD","LU0417516902.SGD","BK1500","CXO","LU1146622755.USD","BK0196","LU1969619763.USD","02367","BK1521","SG9999014674.SGD","LU0348783233.USD","LU1188198961.HKD","02196","LU2495084118.USD","02268","LU0463099449.HKD","BK0028","01789","LU0634319403.HKD","LU1720050803.USD","SG9999004311.SGD","01099","600030","IE00B3M56506.USD","BK1574","KURE","LU1997244956.HKD","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513175","title":"東北證券:創新藥BD和商業化持續兑現 CXO超預期,傳統板塊築底拐點","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513175","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513175?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 09:55","pubTimestamp":1789005326,"startTime":"0","endTime":"0","summary":"东北证券主要观点如下:创新药板块:海外创新药产业高景气延续,国产药企有望承接红利Pharma依托多元路径实现营收稳健增长,Biotech凭借BD和商业化释放业绩弹性。多家创新药企业2026H1业绩超预期增长,这与CXO板块公司的半年度业绩相印证,进一步确认了板块的中期产业趋势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK1161","IBBQ","BK0276","BK0028","BK1574","CXO","BK0183","000686","159992","LNGR","MEDX","06978","WX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665934734","title":"分拆上市成利好?金斯瑞大反攻,飆升逾12%!華寶基金港股通醫療ETF(159137)標的指數漲近2%,CXO全線提振","url":"https://stock-news.laohu8.com/highlight/detail?id=2665934734","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665934734?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 14:06","pubTimestamp":1788847560,"startTime":"0","endTime":"0","summary":"CXO概念集体走强,金斯瑞生物科技飙升逾12%,百奥赛图-B涨超9%,泰格医药、凯莱英涨超7%,药明合联涨超4%。港股通医疗ETF华宝标的指数CXO含量超50%,午后涨近2%!全链布局创新药,关注两大T+0交易利器:港股通医疗ETF华宝:被动跟踪港股通医疗主题指数,重仓创新药产业链,50%CXO+20%创新药,其中药明系占比超38%。港股通创新药ETF华宝:被动跟踪恒生港股通创新药精选指数,100%布局创新药研发类公司,7成仓位押注研发龙头。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-08/doc-inirayqy9498188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["WX","159828","ACTV","CSD","159137","CXO","FLHK","SPIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319763","title":"昊海生科:關於參加科創板2026年半年度生物製品及CXO行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319763","media":"证券日报网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319763?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:43","pubTimestamp":1788777780,"startTime":"0","endTime":"0","summary":"证券日报网讯9月7日,昊海生科发布公告称,公司计划于2026年9月15日15:00-17:00参加由上海证券交易所主办的科创板2026年半年度生物制品及CXO行业集体业绩说明会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-07/doc-iniqyzxu6392948.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-07/doc-iniqyzxu6392948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["WX","BK0239","688366","CXO","BK0251","KSTR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":13,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/WX\",params:#limit:6,delay:false,,,undefined,":[]}}